Home  »  Trending   »  We Analyzed the Future Direction of Vascular Bioge...

We Analyzed the Future Direction of Vascular Biogenics Ltd. (VBLT), Here is What We Found

Vascular Biogenics Ltd. (NASDAQ:VBLT) went up by 12.30% from its latest closing price compared to the recent 1-year high of $2.20. The company’s stock price has collected 10.19% of gains in the last five trading sessions.

Is It Worth Investing in Vascular Biogenics Ltd. (NASDAQ :VBLT) Right Now?

Plus, the 36-month beta value for VBLT is at 0.75. Opinions of the stock are interesting as 0 analysts out of 1 who provided ratings for Vascular Biogenics Ltd. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


The average price from analysts is $5.00, which is $4.84 above the current price. VBLT currently public float of 53.36M and currently shorts hold a 0.11% ratio of that float. Today, the average trading volume of VBLT was 1.27M shares.

VBLT’s Market Performance

VBLT stocks went up by 10.19% for the week, with a monthly jump of 38.05% and a quarterly performance of 17.27%, while its annual performance rate touched -89.55%. The volatility ratio for the week stands at 8.58% while the volatility levels for the past 30 days are set at 10.23% for Vascular Biogenics Ltd. The simple moving average for the period of the last 20 days is 19.46% for VBLT stocks with a simple moving average of -77.32% for the last 200 days.

Analysts’ Opinion of VBLT

Oppenheimer gave a rating of “Outperform” to VBLT, setting the target price at $5.50 in the report published on July 18th of the previous year.

VBLT Trading at 19.31% from the 50-Day Moving Average

After a stumble in the market that brought VBLT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.78% of loss for the given period.

Volatility was left at 10.23%, however, over the last 30 days, the volatility rate increased by 8.58%, as shares surge +44.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +29.29% upper at present.

During the last 5 trading sessions, VBLT rose by +10.19%, which changed the moving average for the period of 200-days by -90.82% in comparison to the 20-day moving average, which settled at $0.1355. In addition, Vascular Biogenics Ltd. saw 32.42% in overturn over a single year, with a tendency to cut further gains.

Stock Fundamentals for VBLT

Current profitability levels for the company are sitting at:

  • -3905.73 for the present operating margin
  • -111.07 for the gross margin

The net margin for Vascular Biogenics Ltd. stands at -3895.83. Equity return is now at value -98.60, with -75.60 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 5.53.

Is SSR Mining Inc. (SSRM) a Keeper?

SSR Mining Inc. (NASDAQ:SSRM) went down by -3.03% from its latest closing price compared to the recent 1-year high of $24.58. The company’s stock price